Evaluated by: Laura W. Lamps, M.D., UAMS Health, July 8, 2016
Original release date: March 1, 2016
Access to this course expires on: March 1, 2019
The promise of personalized medicine has been upon us for years. This course addresses the impact of genomic medicine on patient management, and redefining the role of the pathologist from a diagnostic specialist to a decision maker in the era of personalized medicine. This course is designed for practicing pathologists, molecular lab directors, basic scientists, and pathologists-in-training. The course will be in the form of four presentations that will discuss the impact of genomics on patient care, the phases of implementation and challenges that face the transition into precision medicine, including ethical, QC and training issues. We focus on the real-life examples of molecular testing.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
- The concept of genomic medicine and its scope of applications and impact on cancer management
- The basic principles of the most commonly used tools for molecular profiling and their applications, advantages and limitations,
- Challenges that need to be addressed in moving into personalized medicine.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
Not A Member? Click Here